[1]
|
中华医学会内分泌学分会. 非酒精性脂肪性肝病与相关代谢紊乱诊疗共识(第二版) [J]. 临床肝胆病杂志, 2018, 34(10): 2103-2108.
|
[2]
|
Li, J., Zou, B., Yeo, Y.H., Feng, Y., Xie, X., Lee, D.H., et al. (2019) Prevalence, Incidence, and Outcome of Non-Alcoholic Fatty Liver Disease in Asia, 1999-2019: A Systematic Review and Meta-Analysis. The Lancet Gastroenterology and Hepatology, 4, 389-398. https://doi.org/10.1016/S2468-1253(19)30039-1
|
[3]
|
Lee, R.C., Feinbaum, R.L. and Ambros, V. (1993) The C. elegans Heterochronic Gene lin-4 Encodes Small RNAs with An-tisense Complementarity to lin-14. Cell, 75, 843-854. https://doi.org/10.1016/0092-8674(93)90529-Y
|
[4]
|
Iaquinta, M.R., Lanzillotti, C., Mazziotta, C., Bononi, I., Frontini, F., Mazzoni, E., et al. (2021) The Role of microRNAs in the Osteogenic and Chondrogenic Differentiation of Mesenchymal Stem Cells and Bone Pathologies. Theranostics, 11, 6573-6591. https://doi.org/10.7150/thno.55664
|
[5]
|
Nowosad, K., Hordyjewska-Kowalczyk, E. and Tylzanowski, P. (2020) Mutations in Gene Regulatory Elements Linked to Human Limb Malformations. Journal of Medical Genetics, 57, 361-370.
https://doi.org/10.1136/jmedgenet-2019-106369
|
[6]
|
Huang, P., He, X.-Y. and Xu, M. (2020) The Role of miR-NA-146a and Proinflammatory Cytokines in Carotid Atherosclerosis. BioMed Research International, 2020, Article ID: 6657734. https://doi.org/10.1155/2020/6657734
|
[7]
|
Kondkar, A.A. and Abu-Amero, K.K. (2015) Utility of Cir-culating microRNAs as Clinical Biomarkers for Cardiovascular Diseases. BioMed Research International, 2015, Article ID: 821823. https://doi.org/10.1155/2015/821823
|
[8]
|
Lagos-Quintana, M., Rauhut, R., Lendeckel, W. and Tuschl, T. (2001) Identification of Novel Genes Coding for Small Expressed RNAs. Science, 294, 853-858. https://doi.org/10.1126/science.1064921
|
[9]
|
Surina, S., Fontanella, R.A., Scisciola, L., Marfella, R., Paolisso, G. and Barbieri, M. (2021) miR-21 in Human Cardiomyopathies. Frontiers in Cardiovascular Medicine, 8, Article ID: 767064.
https://doi.org/10.3389/fcvm.2021.767064
|
[10]
|
Ludwig, N., Leidinger, P., Becker, K., Backes, C., Fehlmann, T., Pallasch, C., et al. (2016) Distribution of miRNA Expression across Human Tissues. Nucleic Acids Research, 44, 3865-3877. https://doi.org/10.1093/nar/gkw116
|
[11]
|
Loyer, X., Paradis, V., Hénique, C., Vion, A.-C., Colnot, N., Guerin, C.L., et al. (2016) Liver microRNA-21 Is Overexpressed in Non-Alcoholic Steatohepatitis and Contributes to the Disease in Experimental Models by Inhibiting PPARα Expression. Gut, 65, 1882-1894. https://doi.org/10.1136/gutjnl-2014-308883
|
[12]
|
Zhang, Z., Zha, Y., Hu, W., Huang, Z., Gao, Z., Zang, Y., et al. (2013) The Autoregulatory Feedback Loop of microRNA-21/Programmed Cell Death Protein 4/Activation Protein-1 (MiR-21/PDCD4/AP-1) as a Driving Force for Hepatic Fibrosis Development. Journal of Biological Chemistry, 288, 37082-37093.
https://doi.org/10.1074/jbc.M113.517953
|
[13]
|
Tang, J., Li, X., Cheng, T. and Wu, J. (2021) miR-21-5p/SMAD7 Axis Promotes the Progress of Lung Cancer. Thoracic Cancer, 12, 2307-2313. https://doi.org/10.1111/1759-7714.14060
|
[14]
|
Arghiani, N. and Matin, M.M. (2021) miR-21: A Key Small Mole-cule with Great Effects in Combination Cancer Therapy. Nucleic Acid Therapeutics, 31, 271-283. https://doi.org/10.1089/nat.2020.0914
|
[15]
|
Hong, Y., Ye, M., Wang, F., Fang, J., Wang, C., Luo, J., et al. (2021) MiR-21-3p Promotes Hepatocellular Carcinoma Progression SMAD7/YAP1 Regulation. Frontiers in Oncology, 11, Ar-ticle ID: 642030.
https://doi.org/10.3389/fonc.2021.642030
|
[16]
|
Parlati, L., Régnier, M., Guillou, H. and Postic, C. (2021) New Targets for NAFLD. JHEP Reports, 3, Article ID: 100346. https://doi.org/10.1016/j.jhepr.2021.100346
|
[17]
|
Wu, H., Ng, R., Chen, X., Steer, C.J. and Song, G. (2016) MicroRNA-21 Is a Potential Link between Non-Alcoholic Fatty Liver Disease and Hepatocellular Carcinoma via Modulation of the HBP1-p53-Srebp1c Pathway. Gut, 65, 1850-1860. https://doi.org/10.1136/gutjnl-2014-308430
|
[18]
|
Calo, N., Ramadori, P., Sobolewski, C., Romero, Y., Maeder, C., Fournier, M., et al. (2016) Stress-Activated in Hepatocytes Promotes Lipid and Glucose Metabolic Disorders Associated with High-Fat Diet Consumption. Gut, 65, 1871-1881. https://doi.org/10.1136/gutjnl-2015-310822
|
[19]
|
赵晓云, 邵凯. 微小RNA-21在胰岛素抵抗和糖尿病伴发非酒精性脂肪肝发病中的作用[J]. 中国医学科学院学报, 2016, 38(2): 144-149.
|
[20]
|
Zhang, X., Deng, F., Zhang, Y., Zhang, X., Chen, J. and Jiang, Y. (2021) PPARγ Attenuates He-patic Inflammation and Oxidative Stress of Non-Alcoholic Steatohepatitis via Modulating the miR-21-5p/SFRP5 Path-way. Molecular Medicine Reports, 24, Article No. 823. https://doi.org/10.3892/mmr.2021.12463
|
[21]
|
Oh, C.J., Kim, J.-Y., Min, A.-K., Park, K.-G., Harris, R.A., Kim, H.-J., et al. (2012) Sulforaphane Attenuates Hepatic Fibrosis via NF-E2-Related Factor 2-Mediated Inhibition of Transforming Growth Factor-β/Smad Signaling. Free Radical Biology and Medicine, 52, 671-682. https://doi.org/10.1016/j.freeradbiomed.2011.11.012
|
[22]
|
Mishra, P.J. and Bertino, J.R. (2009) MicroRNA Polymorphisms: The Future of Pharmacogenomics, Molecular Epidemiology and Individualized Medicine. Pharmacogenomics, 10, 399-416. https://doi.org/10.2217/14622416.10.3.399
|
[23]
|
Fabregat, I. and Ca-ballero-Díaz, D. (2018) Transforming Growth Factor-β-Induced Cell Plasticity in Liver Fibrosis and Hepatocarcinogene-sis. Frontiers in Oncology, 8, Article 357. https://doi.org/10.3389/fonc.2018.00357
|
[24]
|
Zhou, X.-L., Xu, H., Liu, Z.-B., Wu, Q.-C., Zhu, R.-R. and Liu, J.-C. (2018) miR-21 Promotes Cardiac Fibroblast-to-Myofibroblast Transfor-mation and Myocardial Fibrosis by Targeting Jagged1. Journal of Cellular and Molecular Medicine, 22, 3816-3824. https://doi.org/10.1111/jcmm.13654
|
[25]
|
Friedman, S.L. (2008) Mechanisms of Hepatic Fibrogenesis. Gastroenterology, 134, 1655-1669.
https://doi.org/10.1053/j.gastro.2008.03.003
|
[26]
|
Derynck, R. and Zhang, Y.E. (2003) Smad-Dependent and Smad-Independent Pathways in TGF-β Family Signalling. Nature, 425, 577-584. https://doi.org/10.1038/nature02006
|
[27]
|
He, X., Xie, J., Zhang, D., Su, Q., Sai, X., Bai, R., et al. (2015) Recom-binant Adeno-Associated Virus-Mediated Inhibition of microRNA-21 Protects Mice Against the Lethal Schistosome In-fection by Repressing Both IL-13 and Transforming Growth Factor Beta 1 Pathways. Hepatology (Baltimore, MD), 61, 2008-2017.
https://doi.org/10.1002/hep.27671
|
[28]
|
Nakao, A., Afrakhte, M., Morén, A., Nakayama, T., Christian, J.L., Heuchel, R., et al. (1997) Identification of Smad7, a TGFβ-Inducible Antagonist of TGF-Beta Signalling. Nature, 389, 631-635. https://doi.org/10.1038/39369
|
[29]
|
Jarman, E.J. and Boulter, L. (2020) Targeting the Wnt Signaling Pathway: The Challenge of Reducing Scarring without Affecting Repair. Expert Opinion on Investigational Drugs, 29, 179-190.
https://doi.org/10.1080/13543784.2020.1718105
|
[30]
|
Tang, M., Jia, H., Chen, S., Yang, B., Patpur, B.K., Song, W., et al. (2021) Significance of MR/OPN/HMGB1 Axis in NAFLD-Associated Hepatic Fibrogenesis. Life Sciences, 264, Article ID: 118619.
https://doi.org/10.1016/j.lfs.2020.118619
|
[31]
|
Wu, K., Ye, C., Lin, L., Chu, Y., Ji, M., Dai, W., et al. (2016) In-hibiting miR-21 Attenuates Experimental Hepatic Fibrosis by Suppressing Both the ERK1 Pathway in HSC and Hepato-cyte EMT. Clinical Science (Lond), 130, 1469-1480.
https://doi.org/10.1042/CS20160334
|
[32]
|
Volinia, S., Calin, G.A., Liu, C.-G., Ambs, S., Cimmino, A., Petrocca, F., et al. (2006) A microRNA Expression Signature of Human Solid Tumors Defines Cancer Gene Targets. Proceedings of the National Academy of Sciences of the United States of America, 103, 2257-2261. https://doi.org/10.1073/pnas.0510565103
|
[33]
|
Zhou, Y., Ren, H., Dai, B., Li, J., Shang, L., Huang, J., et al. (2018) Hepatocellular Carcinoma-Derived Exosomal miRNA-21 Contributes to Tumor Progression by Converting Hepatocyte Stellate Cells to Cancer-Associated Fibroblasts. Journal of Experimental & Clinical Cancer Research, 37, Article No. 324.
https://doi.org/10.1186/s13046-018-0965-2
|
[34]
|
Zhu, Q., Wang, Z., Hu, Y., Li, J., Li, X., Zhou, L., et al. (2012) miR-21 Promotes Migration and Invasion by the miR-21-PDCD4-AP-1 Feedback Loop in Human Hepatocellular Car-cinoma. Oncology Reports, 27, 1660-1668.
https://doi.org/10.3892/or.2012.1682
|
[35]
|
Wang, J., Chu, Y., Xu, M., Zhang, X., Zhou, Y. and Xu, M. (2019) miR-21 Promotes Cell Migration and Invasion of Hepatocellular Carcinoma by Targeting KLF5. Oncology Letters, 17, 2221-2227. https://doi.org/10.3892/ol.2018.9843
|
[36]
|
Yoon, J.S., Kim, G., Lee, Y.R., Park, S.Y., Tak, W.Y., Kweon, Y.-O., et al. (2018) Clinical Significance of microRNA-21 Expression in Disease Progression of Patients with Hepatocellular Carcinoma. Biomarkers in Medicine, 12, 1105-1114. https://doi.org/10.2217/bmm-2018-0096
|
[37]
|
Wagenaar, T.R., Zabludoff, S., Ahn, S.-M., Allerson, C., Arlt, H., Baffa, R., et al. (2015) Anti-miR-21 Suppresses Hepatocellular Carcinoma Growth via Broad Transcriptional Network Deregulation. Molecular Cancer Research, 13, 1009-1021. https://doi.org/10.1158/1541-7786.MCR-14-0703
|
[38]
|
Arrese, M., Eguchi, A. and Feldstein, A.E. (2015) Circu-lating microRNAs: Emerging Biomarkers of Liver Disease. Seminars in Liver Disease, 35, 43-54. https://doi.org/10.1055/s-0034-1397348
|
[39]
|
Yamada, H., Suzuki, K., Ichino, N., Ando, Y., Sawada, A., Osakabe, K., et al. (2013) Associations between Circulating microRNAs (miR-21, miR-34a, miR-122 and miR-451) and Non-Alcoholic Fatty Liver. Clinica Chimica Acta, 424, 99-103. https://doi.org/10.1016/j.cca.2013.05.021
|
[40]
|
Becker, P.P., Rau, M., Schmitt, J., Malsch, C., Hammer, C., Bantel, H., et al. (2015) Performance of Serum microRNAs-122, -192 and -21 as Biomarkers in Patients with Non-Alcoholic Steatohepatitis. PLOS ONE, 10, e0142661.
https://doi.org/10.1371/journal.pone.0142661
|
[41]
|
Sun, C., Huang, F., Liu, X., Xiao, X., Yang, M., Hu, G., et al. (2015) miR-21 Regulates Triglyceride and Cholesterol Metabolism in Non-Alcoholic Fatty Liver Disease by Targeting HMGCR. International Journal of Molecular Medicine, 35, 847-853. https://doi.org/10.3892/ijmm.2015.2076
|
[42]
|
Zhang, H., Ding, R. and Chen, D. (2021) Value of miR-21 Levels as Potential Biomarkers in the Early Diagnosis of Hepatocellular Carcinoma: A Meta-Analysis. Biomarkers, 26, 586-597.
https://doi.org/10.1080/1354750X.2021.1955976
|
[43]
|
Jenike, A.E. and Halushka, M.K. (2021) miR-21: A Non-Specific Biomarker of All Maladies. Biomarker Research, 9, Article No. 18. https://doi.org/10.1186/s40364-021-00272-1
|